anticonvulsants

  • usually initiated after history of 2 seizures

  • generalised

    • sodium valproate

      • except women of child bearing potentioal

        • low dose lamotrigine (\<200mg/day)

        • carbamazepine

  • partial

    • lamotrigine

    • carbamazepine

  • abrupt withdrawal potential to ppt seizures or status epilepticus

  • increase risk of anxiety, depression and suicidlaity

  • decrease mone mineral density and an increase fracture risk

sodium valproate

  • all types of epilepsy

  • adverse effects:

    • common

      • weight gain

      • tremor

      • GI disturbance

      • hair loss

    • thrombocytopenia

    • hepatic failure

    • pancreatitis

    • blood dyscrasia

  • intreactions

    • most other anticonvulsants: raising blood levels

    • TCAs

    • BDZ

    • Warfarin

    • Aspirin

  • Monitoring

    • CBC, LFT, electrolytes

      • bl, 3mo, annually
    • INR - dose decrease may be required

  • regarded less sedating than other anticonvulsant

Carbamazepine

  • Parital epilespises (first-line)

  • also in generalised/mixed

  • may worsen absence or myoclonic seizures

  • Side effects

    • common

      • nausea / vomiting

      • sedation

      • dizziness and ataxia

    • Allergic rash - may be severe

    • leucopenia

    • hyponatraemia

      • action not required if sodium stable above 125mmol/L
    • hepatotoxicity

    • other blood dyscrasia

  • intercations

    • increase plasma concentration

      • azole

      • macrolide

      • ssri

    • induces hepatic enzymes

      • oestrogen/progestogen

      • TCA

      • Warfarin

      • ccb

  • monitoring

    • cbc, lft, electrolyte at baseline
  • use slow release preparations

  • drug of choice in pregnnacy

Lamotrigine

  • ok for most forms of epilepsy

  • alternate first line for partial

  • side effects

    • common

      • allergic rash

      • headache

      • dizziness

      • blurred vision

    • serious allergic rash particularly

      • children

      • dose increased rapidly

      • dose increased rapidly in combination with sodium valproate

  • Interactions

    • concentration increase by sodium valproate

    • decreased by enzyme inducing anticonvulsant oestrogens a nd progestogens

Phenytoin

  • ok for most forms of epilepsy

  • may worsen absence or myoclonic seizures

  • side effects

    • common

      • headahce

      • tiredness

      • nausea

      • dizziness

      • drowsiness

    • allergic rash

    • hirsutism

    • coarsening of facial features

    • acne

    • gingival hyperplasia

    • hepatotoxicity

  • interactions

    • induces hepatic enzymes; reduces effect of:

      • oestrogens and progestogens

      • TCAs

      • warfarin

      • CCB

      • statins

  • Montoring

    • CBC, lft, electolytes

      • bl, 3mo, annually
  • therapeutic drug monitorng is useful due to non-linear pharmacokinetics when adjusting dose or adding additional medicaitons

  • narrow therapeutic index

  • long term toxicity

Dose adjustments

  • may be required for patients with impaired hepatic function

    • most metabolised by liver

    • lower doses required to avoid elevated serum drug levels

    • Gabapentin, pregabalin, levetiracetam excreted without metabolism by liver

      • no dose adjustmnet
  • reduction in renal excretion and/or active metabolites

    • reduce dose
  • lower doses in elderly

  • routine therapeutic drug monitroing limited usefulness

    • except phenytoin
  • small adjustments in phenytoin

special issues

  • females iwth epilepsy

    • main concern = adequate contraception

    • especially carbamazepein adn phenytoin

      • increase metabolism of oestrogen and progestogen

        • reduce effectiveness
    • use at least 50µg of oestrogen

    • mid-cycle bleeding can be an indication that oestrogen dose is inadequate

    • oestrogen dose inc by:

      • 2x30ug/day

      • continuosuly for 3mo wiht 4d break between cycels

      • barrier used concurrently

    • may also reduce effectiveness of POP

    • barrier, depot, iucd, meirena = effective

    • Depo and some anticonvulsants associated with weight gain and lower BMD with long term use

    • if emergency contraception:

      • twice normal dose of ECP

      • IUCD within 5d could be offered as alternative

  • preconception care

    • folic acid 5mg/day

    • continue first trimester

  • pregnancy

    • carbamazepine or lamotrigine in doses \<200mg/day
  • alcohol

    • CNS depressant

    • lowers seizure threshold

    • small amount probably ok

  • epilepsy and driving

    • any person who has a seizure

    • single siezure; without diagnosis = same driving restrictions

    • commercial = loss of license